The Use of Recombinant Activated FVII (rFVIIa, Novoseven) in the Treatment of a Lifethreatening Retroperitoneal Hemorrhage in a Hemophilia A Patient with Inhibitors to FVIII


Autoria(s): Diniz, MJ; Dias, M; Falcão, MT; Cruz, M
Data(s)

24/01/2013

24/01/2013

2000

Identificador

IN: 16th International Congress on Thrombosis, 2000, 5 a 8 Mai. Porto, Portugal

http://hdl.handle.net/10400.17/953

Idioma(s)

eng

Publicador

Serviço de Imuno-Hemoterapia do Hospital de S. José

Direitos

openAccess

Palavras-Chave #Factor VIII #Factor VIIa
Tipo

other